Clinical trial

The SOS (Stenting Of Saphenous Vein Grafts) Trial

NCT00247208 · North Texas Veterans Healthcare System, U.S. Fed · Completed

Key facts

NCT number NCT00247208
Title The SOS (Stenting Of Saphenous Vein Grafts) Trial
Official title The SOS (Stenting Of Saphenous Vein Grafts) Randomized-controlled Trial of a Paclitaxel-eluting Stent vs. a Bare Metal Stent in Saphenous Vein Graft Lesions
Lead sponsor North Texas Veterans Healthcare System, U.S. Fed
Collaborators Clark R. Gregg Fund, Harris Methodist Foundation University of Arkansas US Department of Veterans Affairs U.S. Fed Michael E. DeBakey VA Medical Center Southern Arizona VA Health Care System Onassis…
Status Completed
Phase Phase 3
Study type Interventional
Conditions Coronary Artery Bypass, Arteriosclerosis
Intervention type Device
Interventions Taxus polymer-based paclitaxel-eluting stent, Express 2 bare metal stent
Enrollment 80
Start date May 1, 2005
Primary completion Oct 1, 2008
Completion Jun 1, 2011
First posted Nov 1, 2005
Last update posted Apr 26, 2012
Countries Greece, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies